Hyperthermia treatment improves the effectiveness of chemotherapy and radiotherapy
Hyperthermia treatment in cancer
Statistically, one in three Australians will experience cancer in their lifetime (ABS). Almost all of these patients will undergo surgery and/or radiotherapy and/or chemotherapy as part of their treatment protocol. Approximately 80% of cancer patients seek out a Complementary Therapist in order to receive allied support during or after this treatment process.
Hyperthermia is a method used to treat tumours by increasing the temperature of the cells in a carefully controlled environment. The treatment can be applied in combination with other cancer treatments including radiotherapy and chemotherapy.
Hyperthermia is the most effective radio-sensitiser of tumour tissue in conjunction with radiotherapy. Multiple trials have specifically compared hyperthermia + radiotherapy VS radiotherapy alone and found the combination treatment to be statistically superior with reference to success rate. Similar results are shown with the combination of hyperthermia + chemotherapy: patients are able to enhance the effectiveness and outcomes with the combination.
MIOG provides a unique service: the full integration of hyperthermia with conventional medicines and Evidence Based Complementary Medicine (EBCM) in order to promote the most efficacious outcome for oncology patients.
Learn more: Hyperthermia pricing and packages